190 related articles for article (PubMed ID: 27372568)
1. Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy.
Frick M; Fischer J; Helbling A; Ruëff F; Wieczorek D; Ollert M; Pfützner W; Müller S; Huss-Marp J; Dorn B; Biedermann T; Lidholm J; Ruecker G; Bantleon F; Miehe M; Spillner E; Jakob T
J Allergy Clin Immunol; 2016 Dec; 138(6):1663-1671.e9. PubMed ID: 27372568
[TBL] [Abstract][Full Text] [Related]
2. Component-resolved evaluation of the content of major allergens in therapeutic extracts for specific immunotherapy of honeybee venom allergy.
Blank S; Etzold S; Darsow U; Schiener M; Eberlein B; Russkamp D; Wolf S; Graessel A; Biedermann T; Ollert M; Schmidt-Weber CB
Hum Vaccin Immunother; 2017 Oct; 13(10):2482-2489. PubMed ID: 28494206
[TBL] [Abstract][Full Text] [Related]
3. Component resolution reveals additional major allergens in patients with honeybee venom allergy.
Köhler J; Blank S; Müller S; Bantleon F; Frick M; Huss-Marp J; Lidholm J; Spillner E; Jakob T
J Allergy Clin Immunol; 2014 May; 133(5):1383-9, 1389.e1-6. PubMed ID: 24440283
[TBL] [Abstract][Full Text] [Related]
4. The Honeybee Venom Major Allergen Api m 10 (Icarapin) and Its Role in Diagnostics and Treatment of Hymenoptera Venom Allergy.
Jakob T; Rauber MM; Perez-Riverol A; Spillner E; Blank S
Curr Allergy Asthma Rep; 2020 Jun; 20(9):48. PubMed ID: 32548726
[TBL] [Abstract][Full Text] [Related]
5. IgE-Api m 4 Is Useful for Identifying a Particular Phenotype of Bee Venom Allergy.
Ruiz B; Serrano P; Moreno C
J Investig Allergol Clin Immunol; 2016; 26(6):355-361. PubMed ID: 27996941
[TBL] [Abstract][Full Text] [Related]
6. Api m 10, a genuine A. mellifera venom allergen, is clinically relevant but underrepresented in therapeutic extracts.
Blank S; Seismann H; Michel Y; McIntyre M; Cifuentes L; Braren I; Grunwald T; Darsow U; Ring J; Bredehorst R; Ollert M; Spillner E
Allergy; 2011 Oct; 66(10):1322-9. PubMed ID: 21658068
[TBL] [Abstract][Full Text] [Related]
7. rApi m 3 and rApi m 10 improve detection of honey bee sensitization in Hymenoptera venom-allergic patients with double sensitization to honey bee and yellow jacket venom.
Frick M; Müller S; Bantleon F; Huss-Marp J; Lidholm J; Spillner E; Jakob T
Allergy; 2015 Dec; 70(12):1665-8. PubMed ID: 26259841
[TBL] [Abstract][Full Text] [Related]
8. Evolution of Api m10 Specific IgE and IgG4 After One Year of Bee Venom Immunotherapy.
Pereira Santos MC; Lourenco T; Pereira Barbosa M; Branco Ferreira M
Eur Ann Allergy Clin Immunol; 2020 Jul; 52(4):175-181. PubMed ID: 31939631
[No Abstract] [Full Text] [Related]
9. Hymenoptera venom allergy: analysis of double positivity to honey bee and Vespula venom by estimation of IgE antibodies to species-specific major allergens Api m1 and Ves v5.
Müller UR; Johansen N; Petersen AB; Fromberg-Nielsen J; Haeberli G
Allergy; 2009 Apr; 64(4):543-8. PubMed ID: 19120073
[TBL] [Abstract][Full Text] [Related]
10. Sensitization to Api m 1, Api m 2, and Api m 4: association with safety of bee venom immunotherapy.
Ruiz B; Serrano P; Verdú M; Moreno C
Ann Allergy Asthma Immunol; 2015 Apr; 114(4):350-2. PubMed ID: 25736542
[No Abstract] [Full Text] [Related]
11. IgE to recombinant allergens Api m 1, Ves v 1, and Ves v 5 distinguish double sensitization from crossreaction in venom allergy.
Müller U; Schmid-Grendelmeier P; Hausmann O; Helbling A
Allergy; 2012 Aug; 67(8):1069-73. PubMed ID: 22676144
[TBL] [Abstract][Full Text] [Related]
12. Value of component based diagnostics in IgE-mediated hymenoptera sting reactions.
Neis MM; Merk HF
Cutan Ocul Toxicol; 2012 Jun; 31(2):117-23. PubMed ID: 21995714
[TBL] [Abstract][Full Text] [Related]
13. Cross-Reactive Carbohydrate Determinant in
Abram DM; Fernandes LGR; Perez-Riverol A; Regina Brochetto-Braga M; Zollner RL
Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33050082
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate epitopes as a cause of cross-reactivity in patients allergic to Hymenoptera venom.
Erzen R; Korosec P; Silar M; Music E; Kosnik M
Wien Klin Wochenschr; 2009; 121(9-10):349-52. PubMed ID: 19562300
[TBL] [Abstract][Full Text] [Related]
15. Individual hymenoptera venom compounds induce upregulation of the basophil activation marker ectonucleotide pyrophosphatase/phosphodiesterase 3 (CD203c) in sensitized patients.
Binder M; Fierlbeck G; King Ti; Valent P; Bühring HJ
Int Arch Allergy Immunol; 2002 Oct; 129(2):160-8. PubMed ID: 12403934
[TBL] [Abstract][Full Text] [Related]
16. Sensitization to Hymenoptera venom marker allergens: Prevalence, predisposing factors, and clinical implications.
Stoevesandt J; Hosp C; Kerstan A; Trautmann A
Clin Exp Allergy; 2018 Dec; 48(12):1735-1743. PubMed ID: 30044028
[TBL] [Abstract][Full Text] [Related]
17. IgE recognition of chimeric isoforms of the honeybee (Apis mellifera) venom allergen Api m 10 evaluated by protein array technology.
Van Vaerenbergh M; De Smet L; Rafei-Shamsabadi D; Blank S; Spillner E; Ebo DG; Devreese B; Jakob T; de Graaf DC
Mol Immunol; 2015 Feb; 63(2):449-55. PubMed ID: 25451974
[TBL] [Abstract][Full Text] [Related]
18. The major royal jelly proteins 8 and 9 (Api m 11) are glycosylated components of Apis mellifera venom with allergenic potential beyond carbohydrate-based reactivity.
Blank S; Bantleon FI; McIntyre M; Ollert M; Spillner E
Clin Exp Allergy; 2012 Jun; 42(6):976-85. PubMed ID: 22909169
[TBL] [Abstract][Full Text] [Related]
19. Follow-up of venom immunotherapy (VIT) based on conventional techniques and monitoring of immunoglobulin E to individual venom allergens.
Carballada F; Boquete M; Núñez R; Lombardero M; de la Torre F
J Investig Allergol Clin Immunol; 2010; 20(6):506-13. PubMed ID: 21243935
[TBL] [Abstract][Full Text] [Related]
20. Aedes communis Reactivity Is Associated with Bee Venom Hypersensitivity: An in vitro and in vivo Study.
Scala E; Pirrotta L; Uasuf CG; Mistrello G; Amato S; Guerra EC; Locanto M; Meneguzzi G; Giani M; Cecchi L; Abeni D; Asero R
Int Arch Allergy Immunol; 2018; 176(2):101-105. PubMed ID: 29788016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
